A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to European Union (EU) Sourced Stelara and United States of America (US) Sourced Stelara in Healthy Subjects

NCT04772274 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Ustekinumab

Sponsor

Samsung Bioepis Co., Ltd.